Sight’s use of machine vision has enabled the company to create a deep database of blood imagery that boasts more than half a petabyte of clinical image data. “This library of digitized blood samples is used not just to continue to perfect our AI engine, but also enables us to explore the diagnostic potential of our tech for early detection of serious health conditions like sepsis, cancer, and stroke,” Pollack noted. “While we are still in the early stages of R&D, we hope to be able to expand Sight OLO’s capabilities in the future with this new round of funding.”

Read more here.